Pulmonary artery hypertension (PAH) is defined by a mean pulmonary artery systolic pressure greater than 20 mmHg at rest1,2. It is a progressive and fatal disease characterized by a sustained elevation in pulmonary arterial pressure, leading to right ventricle overload and ultimately death due to right ventricular failure1. Currently, there is no cure for PAH.
The use of animal models of pulmonary hypertension is important for testing the effectiveness of experimental PAH therapies. Among those models, the mouse hypoxia-induced PAH model has provided key insi....